From a largely OEM company, Alphatec has been building its product pipeline with a focus on the aging spine. The question now is, will public investors buy into the vision? by David Cassak Since its a
Archus: Using Old Principles to Open a New Market in Spine By focusing on an overlooked but critical element of spinal anatomy, the facet joint, Archus is applying established principles of total join
With Biomet Inc. 's acquisition of Interpore International Inc. (more familiarly known as Interpore Cross International), we see the latest in a series of moves by leading orthopedic suppliers i
The company's expertise in materials science, including nanotechnology, has been key to its development of synthetic bioactive materials for use in spine surgery. Can it address market risk as effecti